The stem cell approach is the heart of regenerative medicine. In the past few years its promise has become reality with Mayo Clinic delivering regenerative treatments for osteonecrosis, tendonitis and reconstructive surgery.

With the growing interest in regenerative medicine research and treatment, Mayo Clinic established the Regenerative Medicine Biotrust, which helps researchers more efficiently collect samples, process cells and share results.

“The process of harvesting a cell, differentiating it into specialized tissues, expanding it into big numbers, then using them for real applications in research, clinical applications, clinical trials, etc. – that’s complicated,” says Dennis Wigle, M.D., Ph.D., director of the Regenerative Medicine Biotrust. “You need an infrastructure to be able to do that.”

Building on Mayo Clinic’s expertise in biobanking, the Regenerative Medicine Biotrust gives researchers and clinicians access to living cells. The approach will fast-track discovery, accelerating the time-consuming processes of specimen collection and conversion. In this way, teams of scientists and clinicians will develop focused questions and go right to the prepared cells to find the answer.

 “The Biotrust puts Mayo at the cutting edge in investigating how fast we can make new technologies, apply new technologies and do it for real clinical care,” Dr. Wigle says. “This will advance regenerative solutions for our patients.”

To learn more, watch the video below:
http://youtu.be/Vwgx2Ie8HQg

Tags: Biobusiness, biotrust, dennis wigle, Mayo Clinic, regenerative medicine, Research, stem cells